NDC 61269-450

Cytovene IV

Ganciclovir Sodium

Cytovene IV is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by H2-pharma, Llc. The primary component is Ganciclovir Sodium.

Product ID61269-450_21f3f765-c9da-4d2a-a0b2-f3af9a25ffc4
NDC61269-450
Product TypeHuman Prescription Drug
Proprietary NameCytovene IV
Generic NameGanciclovir Sodium
Dosage FormInjection, Powder, Lyophilized, For Solution
Route of AdministrationINTRAVENOUS
Marketing Start Date1989-06-23
Marketing CategoryNDA / NDA
Application NumberNDA019661
Labeler NameH2-Pharma, LLC
Substance NameGANCICLOVIR SODIUM
Active Ingredient Strength500 mg/10mL
Pharm ClassesCytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],DNA Polymerase Inhibitors [MoA],Nucleoside Analog [EXT],Nucleoside Analog Antiviral [EPC]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 61269-450-50

5 VIAL in 1 CARTON (61269-450-50) > 10 mL in 1 VIAL
Marketing Start Date1989-06-23
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 61269-450-20 [61269045020]

Cytovene IV INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Marketing CategoryNDA
Application NumberNDA019661
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1989-06-23

Drug Details

Active Ingredients

IngredientStrength
GANCICLOVIR SODIUM500 mg/10mL

Pharmacological Class

  • Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
  • DNA Polymerase Inhibitors [MoA]
  • Nucleoside Analog [EXT]
  • Nucleoside Analog Antiviral [EPC]
  • Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
  • DNA Polymerase Inhibitors [MoA]
  • Nucleoside Analog [EXT]
  • Nucleoside Analog Antiviral [EPC]

NDC Crossover Matching brand name "Cytovene IV" or generic name "Ganciclovir Sodium"

NDCBrand NameGeneric Name
0004-6940Cytoveneganciclovir sodium
61269-450Cytoveneganciclovir sodium
0143-9299GanciclovirGanciclovir sodium
14335-030Ganciclovirganciclovir sodium
25021-185ganciclovirganciclovir sodium
51817-171Ganciclovirganciclovir sodium
63323-315GanciclovirGANCICLOVIR SODIUM
70436-089Ganciclovirganciclovir sodium
76233-072GanciclovirGanciclovir Sodium

Trademark Results [Cytovene]

Mark Image

Registration | Serial
Company
Trademark
Application Date
CYTOVENE
CYTOVENE
73632978 1444841 Live/Registered
SYNTEX (U.S.A.) INC.
1986-11-28

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.